Reckitt Spends $3.3 Bil. On Boots, Gains Clearasil Anti-Acne Brand
This article was originally published in The Rose Sheet
Executive Summary
Reckitt Benckiser's $3.3 bil. (£1.9 bil.) cash purchase of Boots Healthcare International establishes the company as a significant player in the OTC consumer products market
You may also be interested in...
Reckitt Grows Its Personal-Care Clout, Asia Footprint With $724M Paras Buy
Reckitt Benckiser will enhance its personal-care offering and position itself for growth in the dynamic Indian market with its acquisition of Paras Pharmaceuticals Ltd. for roughly $725 million.
Reckitt Grows Its Personal-Care Clout, Asia Footprint With $724M Paras Buy
Reckitt Benckiser will enhance its personal-care offering and position itself for growth in the dynamic Indian market with its acquisition of Paras Pharmaceuticals Ltd. for roughly $725 million.
Reckitt Benckiser Is Focus Of Acquisition Speculation In Personal Care
As consumer products merger and acquisition activity revives, analysts are speculating about which players in the personal-care arena may be winding up for deals, with UK-based Reckitt Benckiser considered a likely suspect